Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Br J Cancer ; 130(1): 9-18, 2024 01.
Article in English | MEDLINE | ID: mdl-37898721

ABSTRACT

Adenocarcinoma of the oesophagus and gastro-oesophageal junction represent a large burden of cancer death in the Western World with an increasing incidence. In the past two decades, the overall survival of patients on a potentially curative treatment pathway has more than doubled due to the addition of perioperative oncological therapies to surgery. However, patients often fail to respond to oncological treatment or struggle to complete their treatment after surgery. In this review, we discuss the current evidence for total neoadjuvant therapy and options for assessment of treatment response.


Subject(s)
Adenocarcinoma , Esophageal Neoplasms , Humans , Neoadjuvant Therapy , Esophageal Neoplasms/drug therapy , Adenocarcinoma/drug therapy , Esophagogastric Junction
2.
Scott Med J ; 67(1): 30-37, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34939516

ABSTRACT

BACKGROUND: There are limited options for men with large benign prostates (>150cc) and bladder outflow obstruction due to benign prostatic hyperplasia (BPH). Management options include surgery (open or minimal access) and endoscopic procedures. There is a paucity of literature on outcomes for prostates >150cc. METHODS: In this case series we describe a step-by-step, illustrated, modified extra-peritoneal technique of laparoscopic prostatectomy with preservation of the posterior prostatic urethra. This involves creation of extra-peritoneal space, transverse incision of prostate capsule, progressive adenoma dissection, resection, and closure of the capsule. RESULTS: Ten patients underwent this procedure between 2015 and 2019. The mean age was 72.4 years and mean prostate size was 215.5cc. Mean procedure duration was 200 min and there were no intraoperative complications. Most patients were discharged on postoperative day 1. Mean intraoperative blood loss was 120 ml with no patient requiring blood transfusion. At follow up (mean 37 months) no patients had residual symptoms of BPH. CONCLUSION: We describe a novel extraperitoneal laparoscopic technique for benign prostates of >150cc with very good outcomes. The transferability of this technique to centres with laparoscopic expertise at minimal extra cost and future adaptability in the robotic setting are some of the advantages of this technique.


Subject(s)
Adenoma , Laparoscopy , Prostatic Hyperplasia , Adenoma/complications , Adenoma/surgery , Aged , Humans , Laparoscopy/methods , Male , Prostate/surgery , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/surgery , Urethra/surgery
SELECTION OF CITATIONS
SEARCH DETAIL